POTENSI ZAT AKTIF ANTIKANKER SOLASODIN TERENKAPUSULASI PADA ZEOLIT KLINOPTILOLIT SEBAGAI SISTEM PENGANTAR OBAT (DRUG DELIVERY SYSTEM)

  • I Made Wisnu Adhi Putra Program Studi Ilmu Gizi, Fakultas Ilmu Kesehatan, Sains dan Teknologi, Universitas Dhyana Pura
  • I Gede Mustika Program Studi Ilmu Gizi, Fakultas Ilmu Kesehatan, Sains dan Teknologi, Universitas Dhyana Pura

Abstract

Sistem penghantar obat merupakan formulasi obat atau alat yang memungkinkan pemasukan obat ke dalam tubuh dan meningkatkan kemanjuran dan keamanan obat dengan mengontrol laju, waktu, dan situs lepas obat di dalam tubuh. Dalam penelitian ini, sistem penghantar obat dibuat dengan enkapsulasi senyawa aktif antikanker solasodin (SSD) pada zeolit klinoptilolit (CLI) dengan variasi konsentrasi larutan awal solasodin. Sistem penghantar obat hasil sintesis dikarakterisasi menggunakan FTIR, XRD dan N2 sorption analyzer. Jumlah solasodin terenkapsulasi dihitung menggunakan metode gravimetri sederhana. Hasil karakterisasi menggunakan FTIR menunjukkan tidak terjadi perubahan gugus fungsi pada zeolit ketika solasodin dienkapsulasi. Hasil XRD juga menyatakan bahwa tidak terjadi perubahan struktur kristal pada zeolit karena enkapsualasi solasodin. Luas permukaan zeolit ditemukan menurun ketika solasodin terenkapsulasi. Enkapsulasi solasodin pada zeolit klinoptilolit secara optimum terjadi pada pH 9. Jumlah solasodin terenkapsulasi secara maksimum terjadi pada konsentrasi larutan awal solasodin 250 mg/L. Uji in vitro menunjukkan bahwa pelepasan solasodin tidak terjadi pada cairan lambung simulasi (pH 1,2) selama 12 jam. Pada cairan usus simulasi (pH 7,4), solasodin perlahan-lahan lepas pada 4 jam pertama, meningkat drastis pada jam ke-5, dan menurun perlahan-lahan pada jam ke-6 sampai jam ke-12.

 

Drug delivery system (DDS) is drug formulation or device that allows the drugs administration within the body and increases drug efficacy and safety by controlling drugs rate, time, and release sites in the body. In this research, we made drug delivery systems by encapsulating anticancer active compound solasodine (SSD) into clinoptilolite zeolite (CLI) with the variation of initial concentration of solasodine. The as-synthetized drug delivery systems were then characterized by using FTIR, XRD and N2 sorption analyzer. The amount of solasodine encapsulated on zeolite was calculated by using simple gravimetric method. FTIR results showed that there were no alteration in functional groups of zeolite when solasodine encapsulated into zeolite. XRD results also confirmed that there were no zeolite crystalline structure changes after the encapsulation of solasodine. Surface area of zeolite was found to decrease as the solasodine encapsulated into zeolites. Based on the effect of pH test, it was found that the maximum amount of solasodine encapsulated into zeolite structure was occurred at pH of 9. Meanwhile, the encapsulation of solasodine in various concentrations reached the maximum at the concentration of solasodine of 250 mg/L. The release of solasodine did not happen in simulated gastric solution (pH of 1.2) over 12 hours. In simulated intestine solution (pH of 7.4), solasodine was gradually released in the first four hours, drastically released in the fifth hour, and gradually released again in the sixth hour until twelfth hour.

Downloads

Download data is not yet available.

References

[1] Vadia, N.,Rajput, S. Mesoporous Material, MCM­41: A New Drug Carrier. AsianJ. Pharm. Clin. Res.2011, 4(2), 44-53.

[2] Hirvonen, J., Laaksonen, T., Peltonen, L., Santos, H., Lehto, V-P., Heikkilä, T., Riikonen, J., Mäkilä, E., & Salonen, J. Feasibility of Silicon-Based MesoporousMaterials for Oral Drug DeliveryApplications. Dosis.2008, 24(2), 129-149.

[3] Yunos, N.H.M., Hamdan, H., & Ling, L.S. Piperine Loaded Silica Aerogel and Silica Xerogel as NANO-Enabled Drug Delivery System. World Appl. Sci. J.(Special Issue of Nanotechnology). 2010, 9, 6-16.

[4] Wang, Z., Chen, B., Quan, G., Li, F., Wu, Q., Dian, L., Dong, Y., Li, G., &Wu, C. Increasing the Oral Bioavailability of Poorly Watersoluble Carbamazepine Using Immediate-Release Pellets Supported on SBA-15 Mesoporous Silica.Int. J. Nanomed.2012, 7, 5807-5818.

[5] Ganesh, M., &Lee, S.G. Synthesis, Characterization and Drug Release Capability of NewCost Effective Mesoporous Silica Nano Particle forIbuprofen Drug Delivery. Int. J. Control Autom.2013.6(5), 207-216.

[6] Amorim, R., Vilaça, N., Martinho, O., Reis, R.M., Sardo, M., Rocha, J., Fonseca, A.M., Baltazar, F. and Neves, I.C. Zeolite Structures Loading with an Anticancer Compound As DrugDelivery Systems. J. Phys. Chem. C.2012, 116(48), 25642-25650.

[7] Milenkovic, J., Hrenovic, J., Goic-Barišic, I. &Rajic, N. Antibacterial Activity of Metal-Loaded NaturalZeolite Against Clinical Isolates of AcinetobacterBaumannii, Proceedings of the 5thSerbian-Croatian-Slovenian Symposium on Zeolites. Zlatibor, 2013.

[8] Can, C., Körlü, A. & Ates, M. Use of Silver-Loaded Zeolites in TheAntibacterial Finishing of Cotton Fabrics. Tekst. Konfeksiyon.2013,23(1), 32-37.

[9] Grancarić, A.M., Tarbuk, A., &Kovacek, I. Nanoparticles of Activated NaturalZeolite on Textiles For Protection and Therapy. Chem. Ind. Chem. Eng. Q.2009, 15(4),203-210.

[10] Cisneros, V., Ocanto, F., & Linares, C.F. Ca2+, Mg2+ or Fe2+ Ion-Exchanged Cancrinite-Type Zeolites as Possible Hypoglycemiant Agents. Rev.Latinoamer.Quím.2011,39(1-2),55-61.

[11] Soldatkin, O.O., Shelyakina, M.K., Arkhypova, V.N., Soy, E., Kirdeciler, S.K., Kasap, B.O., Lagarde, F., Jaffrezic-Renault, N., Kurç, B.U., Soldatkin, A.P., & Dzyadevych, S.V. Nano-and Microsized Zeolites as A Perspectivematerial for Potentiometric Biosensors Creation. Nanoscale Res. Lett.2015, 10(59).

[12] Montinaro, M., Uberti, D., Maccarinelli, G., Bonini, S.A., Ferrari-Toninelli, G., & Memo, M. Dietary Zeolite Supplementation Reduces Oxidative Damage and Plaque Generation in The Brain of An Alzheimer's Disease Mouse Model. Life Sci. 2013, 92(17-19), 903-910.

[13] Jevtić, S., Grujić, S., Hrenović, J., & Rajić, N. Surfactant-Modified Clinoptilolite as a Salicylate Carrier, Salicylate Kinetic Release and Its Antibacterial Activity. Micropor. Mesopor. Mat. 2012, 159, 30-35.

[14] Umadevi, M., Sampath Kumar, K.P., Bhowmik, D., & Duraivel, S. Traditionally Used Anticancer Herbs In India. J. Med. Plants Stud. 2013,1(3), 56-74.

[15] Zha, X.M., Zhang, F.R., Shan, J.Q., Zhang, Y.H., Liu, J.O., & Sun, H.B. Synthesis and evaluation of in vitro anticancer activity of novel solasodine derivatives. Chinese Chem. Lett.2010, 21(9), 1087-1090.

[16] Bhattacharya, S., Kohli, S., & Chaudhary, A.S. Designing and Development of Solasodine Nanoparticles for Cancer Therapy (Part A). Austral-Asian Journal of Cancer. 2013, 12(4), 253-268.

[17] Ryndina, S.E., Shaskina, L.F., & Starkov, M.V. Toxicity of Solasodine and Solasodine Diosgenin. Pharm. Chem. J.1997, 11(8), 1095-1100.

[18] Vilaҫa, N., Amorim, R., Machado, A.F., Parpot, P., et al. Potentiation of 5-fluorouracil in Zeolites as Drug Delivery Systems for in vitro Models of Colorectal Carcinoma. Colloids Surf. B. Biointerfaces.2013, 112, 237-244.

[19] Pavelić, K., Hadžija, M., Bedrica, L., Pavelić, J., Dikić, I., Katić, M., Kralj, M., Bosnar, M. H., Kapitanović, S., Poljak-Blaži, M., Križanac, S., Stojković, R., Jurin, M., Subotić, B., & Colić, M. Natural zeolite clinoptilolite: new adjuvant in anticancer therapy. J. Mol. Med.2000, 1-6.

[20] Datta, M.,& Kaur, M. In Vitro Release Of Sodium Diclofenac From Poloxamer 188 ModifiedMontmorillonite As An Oral Drug Delivery Vehicle. Int. J. Pharm. Pharm. Sci.2014, 6(5), 100-110.

[21] Datt, A., Burns, E. A., Dhuna, N. A. and Larsen, S. C. Loading and release of 5-fluorouracil from HY zeolites with varying SiO2/Al2O3 ratios. Micropor.Mesopor. Mater.2013, 167, 182–187.

[22] Khodaverdi, E., Soleimani, H.A., Mohammadpour, F., Hadizadeh, F. Synthetic Zeolites as Controlled-Release Delivery Systems for Anti-Inflammatory Drugs. Chem. Biol. Drug. Des. 2016, 87, 849–857.

[23] Eren, Z. S., Tunçer, S., Gezer, G., Yildirim, L. T., Banerjee, S. and Yilmaz, A. Improved Solubility of Celecoxib by Inclusion in SBA-15 Mesoporous Silica, Drug Loading in Different Solvents and Release. Micropor. Mesopor. Mater. 2016,235, 211-223.

[24] Khodaverdi, E., Honarmandi, R., Alibolandi, M., Baygi, R.R., Hadizadeh, F., Zohuri, G. Evaluation of synthetic zeolites as oral delivery vehicle for anti-inflammatory drugs. Iran. J. Basic Med. Sci. 2014, 17, 337-343.
Published
2017-03-02
How to Cite
ADHI PUTRA, I Made Wisnu; MUSTIKA, I Gede. POTENSI ZAT AKTIF ANTIKANKER SOLASODIN TERENKAPUSULASI PADA ZEOLIT KLINOPTILOLIT SEBAGAI SISTEM PENGANTAR OBAT (DRUG DELIVERY SYSTEM). CAKRA KIMIA (Indonesian E-Journal of Applied Chemistry), [S.l.], v. 4, n. 2, p. 103-112, mar. 2017. ISSN 2302-7274. Available at: <https://ojs.unud.ac.id/index.php/cakra/article/view/28922>. Date accessed: 29 sep. 2022.
Section
Articles

Keywords

Drug delivery system; solasodine; zeolite; encapsulation